{
  "peptideCard" : {
    "id" : 6523,
    "name" : "C41 [S20X]",
    "seq" : "EWDREINNYTSLIHSLIEEXQNQQEKNEQELLELDKWASLW",
    "seqLength" : 41,
    "nTerminus" : "#",
    "cTerminus" : "#",
    "synthesisType" : "Synthetic",
    "complexity" : "Monomer",
    "targetGroups" : [ "Virus" ],
    "targets" : [ "gp41" ],
    "unusualAminoAcids" : [ {
      "position" : 20,
      "modificationType" : "PEG750-CYS"
    } ],
    "targetActivities" : [ {
      "targetSpecies" : "HIV-1",
      "activityMeasure" : "IC50",
      "concentration" : ">0.4",
      "unit" : "µM",
      "ionicStrength" : ".",
      "note" : "Inhibition of cell-cell fusion.",
      "reference" : "1"
    } ],
    "articles" : [ {
      "journal" : "Bioconjug Chem",
      "articleYear" : 2012,
      "volume" : "23",
      "pages" : "1648-1660",
      "title" : "Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.",
      "pubMed" : "22770564",
      "authors" : [ "Danial M", "van Dulmen TH", "Aleksandrowicz J", "Pötgens AJ", "Klok HA" ]
    } ]
  }
}